<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37892261</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9067</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>25</Day></PubDate></JournalIssue><Title>Children (Basel, Switzerland)</Title><ISOAbbreviation>Children (Basel)</ISOAbbreviation></Journal><ArticleTitle>Atopy and Elevation of IgE, IgG3, and IgG4 May Be Risk Factors for Post COVID-19 Condition in Children and Adolescents.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1598</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/children10101598</ELocationID><Abstract><AbstractText>SARS-CoV-2 infection causes transient cardiorespiratory and neurological disorders, and severe acute illness is rare among children. Post COVID-19 condition (PCC) may cause profound, persistent phenotypes with increasing prevalence. Its manifestation and risk factors remain elusive. In this monocentric study, we hypothesized that atopy, the tendency to produce an exaggerated immunoglobulin E (IgE) immune response, is a risk factor for the manifestation of pediatric PCC. We present a patient cohort (n = 28) from an early pandemic period (2021-2022) with comprehensive evaluations of phenotypes, pulmonary function, and molecular investigations. PCC predominantly affected adolescents and presented with fatigue, dyspnea, and post-exertional malaise. Sensitizations to aeroallergens were found in 93% of cases. We observed elevated IgE levels (mean 174.2 kU/L, reference &lt; 100 kU/L) regardless of disease severity. Concurrent Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) was found in 29% of patients that also faced challenges in school attendance. ME/CFS manifestation was significantly associated with elevated immunoglobulin G subclasses IgG3 (<i>p</i> &lt; 0.05) and IgG4 (<i>p</i> &lt; 0.05). A total of 57% of patients showed self-limiting disease courses with mean recovery at 12.7 months (range 5-25 months), 29% at 19.2 months (range 12-30 months), and the rest demonstrated overall improvement. These findings offer additional insights into immune dysregulation as a risk factor for pediatric PCC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>K&#xf6;rner</LastName><ForeName>Robert Walter</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0003-3164-4952</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bansemir</LastName><ForeName>Ole Yannick</ForeName><Initials>OY</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franke</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sturm</LastName><ForeName>Julius</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dafsari</LastName><ForeName>Hormos Salimi</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Rare Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Max-Planck-Institute for Biology of Ageing, 50931 Cologne, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>413543196</GrantID><Agency>Cologne Clinician Scientist Program / Medical Faculty / University of Cologne and German Research Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Children (Basel)</MedlineTA><NlmUniqueID>101648936</NlmUniqueID><ISSNLinking>2227-9067</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">adolescents</Keyword><Keyword MajorTopicYN="N">atopic disease</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post COVID-19 condition</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>11</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37892261</ArticleId><ArticleId IdType="pmc">PMC10605545</ArticleId><ArticleId IdType="doi">10.3390/children10101598</ArticleId><ArticleId IdType="pii">children10101598</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinsohn T., Lange B., Vanella P., Rodiah I., Glockner S., Joachim A., Becker D., Brandle T., Dhein S., Ehehalt S., et al. Infection and transmission risks of COVID-19 in schools and their contribution to population infections in Germany: A retrospective observational study using nationwide and regional health and education agency notification data. PLoS Med. 2022;19:e1003913. doi: 10.1371/journal.pmed.1003913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003913</ArticleId><ArticleId IdType="pmc">PMC9767368</ArticleId><ArticleId IdType="pubmed">36538517</ArticleId></ArticleIdList></Reference><Reference><Citation>Viner R.M., Russell S.J., Croker H., Packer J., Ward J., Stansfield C., Mytton O., Bonell C., Booy R. School closure and management practices during coronavirus outbreaks including COVID-19: A rapid systematic review. Lancet Child Adolesc. Health. 2020;4:397&#x2013;404. doi: 10.1016/S2352-4642(20)30095-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30095-X</ArticleId><ArticleId IdType="pmc">PMC7270629</ArticleId><ArticleId IdType="pubmed">32272089</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Allin B., Nugawela M.D., Rojas N., Dalrymple E., Pinto Pereira S., Soni M., Knight M., Cheung E.Y., Heyman I., et al. Long COVID (post-COVID-19 condition) in children: A modified Delphi process. Arch. Dis. Child. 2022;107:674&#x2013;680. doi: 10.1136/archdischild-2021-323624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-323624</ArticleId><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Ayuzo Del Valle N.C., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. Long-COVID in children and adolescents: A systematic review and meta-analyses. Sci. Rep. 2022;12:9950. doi: 10.1038/s41598-022-13495-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Atchison C.J., Whitaker M., Donnelly C.A., Chadeau-Hyam M., Riley S., Darzi A., Ashby D., Barclay W., Cooke G.S., Elliott P., et al. Characteristics and predictors of persistent symptoms post-COVID-19 in children and young people: A large community cross-sectional study in England. Arch. Dis. Child. 2023;108:e12. doi: 10.1136/archdischild-2022-325152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2022-325152</ArticleId><ArticleId IdType="pmc">PMC10313975</ArticleId><ArticleId IdType="pubmed">36863848</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostev K., Smith L., Koyanagi A., Konrad M., Jacob L. Post-COVID-19 conditions in children and adolescents diagnosed with COVID-19. Pediatr. Res. 2022:1&#x2013;6. doi: 10.1038/s41390-022-02111-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-022-02111-x</ArticleId><ArticleId IdType="pmc">PMC9107066</ArticleId><ArticleId IdType="pubmed">35568733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh R., Grach S.L., Ghosh A.K., Bierle D.M., Salonen B.R., Collins N.M., Joshi A.Y., Boeder N.D., Jr., Anstine C.V., Mueller M.R., et al. The Female-Predominant Persistent Immune Dysregulation of the Post-COVID Syndrome. Mayo Clin. Proc. 2022;97:454&#x2013;464. doi: 10.1016/j.mayocp.2021.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.11.033</ArticleId><ArticleId IdType="pmc">PMC8817110</ArticleId><ArticleId IdType="pubmed">35135695</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk Factors Associated with Post-COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern. Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogensen I., Ekstrom S., Hallberg J., Georgelis A., Melen E., Bergstrom A., Kull I. Post COVID-19 symptoms are common, also among young adults in the general population. Sci. Rep. 2023;13:11300. doi: 10.1038/s41598-023-38315-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-38315-2</ArticleId><ArticleId IdType="pmc">PMC10338459</ArticleId><ArticleId IdType="pubmed">37438424</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen S.F. Epidemiology and natural history of atopic diseases. Eur. Clin. Respir. J. 2015;2:24642. doi: 10.3402/ecrj.v2.24642.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/ecrj.v2.24642</ArticleId><ArticleId IdType="pmc">PMC4629767</ArticleId><ArticleId IdType="pubmed">26557262</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafsari H.S., Ebrahimi-Fakhari D., Saffari A., Deneubourg C., Fanto M., Jungbluth H. EPG5-Related Disorder. In: Adam M.P., Mirzaa G.M., Pagon R.A., Wallace S.E., Bean L.J.H., Gripp K.W., Amemiya A., editors. GeneReviews&#xae;. University of Washington; Seattle, WA, USA: 1993.</Citation><ArticleIdList><ArticleId IdType="pubmed">36228046</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafsari H.S., Pemberton J.G., Ferrer E.A., Yammine T., Farra C., Mohammadi M.H., Ghayoor Karimiani E., Hashemi N., Souaid M., Sabbagh S., et al. PI4K2A deficiency causes innate error in intracellular trafficking with developmental and epileptic-dyskinetic encephalopathy. Ann. Clin. Transl. Neurol. 2022;9:1345&#x2013;1358. doi: 10.1002/acn3.51634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51634</ArticleId><ArticleId IdType="pmc">PMC9463957</ArticleId><ArticleId IdType="pubmed">35880319</ArticleId></ArticleIdList></Reference><Reference><Citation>Brindisi G., De Vittori V., De Nola R., Pignataro E., Anania C., De Castro G., Cinicola B., Gori A., Cicinelli E., Zicari A.M. Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak. J. Clin. Med. 2021;10:2278. doi: 10.3390/jcm10112278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10112278</ArticleId><ArticleId IdType="pmc">PMC8197398</ArticleId><ArticleId IdType="pubmed">34073986</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi G.F., Diaferio L., Brindisi G., Indolfi C., Umano G.R., Klain A., Marchese G., Ghiglioni D.G., Zicari A.M., Marseglia G.L., et al. Cross-Sectional Survey on Long Term Sequelae of Pediatric COVID-19 among Italian Pediatricians. Child. 2021;8:769. doi: 10.3390/children8090769.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children8090769</ArticleId><ArticleId IdType="pmc">PMC8467017</ArticleId><ArticleId IdType="pubmed">34572201</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., van de Sande M.I., De Meirleir K.L., Klimas N.G., Broderick G., Mitchell T., Staines D., Powles A.C., Speight N., Vallings R., et al. Myalgic encephalomyelitis: International Consensus Criteria. J. Intern. Med. 2011;270:327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Korner R.W., Weber L.T. Prevalence of COVID-19 Among Children and Adolescents While Easing Lockdown Restrictions in Cologne, North Rhine-Westphalia, Germany. Klin. Padiatr. 2021;233:135&#x2013;140. doi: 10.1055/a-1341-9530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1341-9530</ArticleId><ArticleId IdType="pubmed">33461226</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Santa Cruz A., Mendes-Frias A., Azarias-da-Silva M., Andre S., Oliveira A.I., Pires O., Mendes M., Oliveira B., Braga M., Lopes J.R., et al. Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8(+)beta7 integrin(+) T cells and anti-SARS-CoV-2 IgA response. Nat. Commun. 2023;14:1772. doi: 10.1038/s41467-023-37368-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-37368-1</ArticleId><ArticleId IdType="pmc">PMC10061413</ArticleId><ArticleId IdType="pubmed">36997530</ArticleId></ArticleIdList></Reference><Reference><Citation>Irfan O., Muttalib F., Tang K., Jiang L., Lassi Z.S., Bhutta Z. Clinical characteristics, treatment and outcomes of paediatric COVID-19: A systematic review and meta-analysis. Arch. Dis. Child. 2021;106:440&#x2013;448. doi: 10.1136/archdischild-2020-321385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-321385</ArticleId><ArticleId IdType="pmc">PMC8070630</ArticleId><ArticleId IdType="pubmed">33593743</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y.B., Zeng N., Yuan K., Tian S.S., Yang Y.B., Gao N., Chen X., Zhang A.Y., Kondratiuk A.L., Shi P.P., et al. Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review. J. Infect. Public Health. 2023;16:660&#x2013;672. doi: 10.1016/j.jiph.2023.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.03.005</ArticleId><ArticleId IdType="pmc">PMC9990879</ArticleId><ArticleId IdType="pubmed">36931142</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello R., Mariani F., Mastrantoni L., De Rose C., Zampino G., Munblit D., Sigfrid L., Valentini P., Buonsenso D. Risk factors for post-COVID-19 condition (Long Covid) in children: A prospective cohort study. EClinicalMedicine. 2023;59:101961. doi: 10.1016/j.eclinm.2023.101961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101961</ArticleId><ArticleId IdType="pmc">PMC10101848</ArticleId><ArticleId IdType="pubmed">37073325</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin J., Di Maio J., Weeraratne T., Kennedy K.M., Oliver L.K., Bouchard M., Malhotra D., Habashy J., Ding J., Bhopa S., et al. Resilience in adolescence during the COVID-19 crisis in Canada. BMC Public Health. 2023;23:1097. doi: 10.1186/s12889-023-15813-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-15813-6</ArticleId><ArticleId IdType="pmc">PMC10243272</ArticleId><ArticleId IdType="pubmed">37280549</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F., Blanco J., Capelli E., Castro-Marrero J., Steiner S., Murovska M., Scheibenbogen C., European Network on MC Myalgic Encephalomyelitis/Chronic Fatigue Syndrome&#x2014;Evidence for an autoimmune disease. Autoimmun. Rev. 2018;17:601&#x2013;609. doi: 10.1016/j.autrev.2018.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.01.009</ArticleId><ArticleId IdType="pubmed">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiss R., Tan L., Schmidt S., Regensburger A.P., Ewert F., Mammadova D., Buehler A., Vogel-Claussen J., Voskrebenzev A., Rauh M., et al. Pulmonary Dysfunction after Pediatric COVID-19. Radiology. 2023;306:e221250. doi: 10.1148/radiol.221250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.221250</ArticleId><ArticleId IdType="pmc">PMC9513839</ArticleId><ArticleId IdType="pubmed">36125379</ArticleId></ArticleIdList></Reference><Reference><Citation>Remy-Jardin M., Duthoit L., Perez T., Felloni P., Faivre J.B., Fry S., Bautin N., Chenivesse C., Remy J., Duhamel A. Assessment of pulmonary arterial circulation 3 months after hospitalization for SARS-CoV-2 pneumonia: Dual-energy CT (DECT) angiographic study in 55 patients. EClinicalMedicine. 2021;34:100778. doi: 10.1016/j.eclinm.2021.100778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100778</ArticleId><ArticleId IdType="pmc">PMC8008988</ArticleId><ArticleId IdType="pubmed">33817609</ArticleId></ArticleIdList></Reference><Reference><Citation>George P.M., Reed A., Desai S.R., Devaraj A., Faiez T.S., Laverty S., Kanwal A., Esneau C., Liu M.K.C., Kamal F., et al. A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae. Sci. Transl. Med. 2022;14:eabo5795. doi: 10.1126/scitranslmed.abo5795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abo5795</ArticleId><ArticleId IdType="pubmed">36383686</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniscalco M., Ambrosino P., Poto R., Fuschillo S., Poto S., Matera M.G., Cazzola M. Can FeNO be a biomarker in the post-COVID-19 patients monitoring? Respir. Med. 2022;193:106745. doi: 10.1016/j.rmed.2022.106745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2022.106745</ArticleId><ArticleId IdType="pmc">PMC8789557</ArticleId><ArticleId IdType="pubmed">35114576</ArticleId></ArticleIdList></Reference><Reference><Citation>Kooner H.K., McIntosh M.J., Matheson A.M., Venegas C., Radadia N., Ho T., Haider E.A., Konyer N.B., Santyr G.E., Albert M.S., et al. (129)Xe MRI ventilation defects in ever-hospitalised and never-hospitalised people with post-acute COVID-19 syndrome. BMJ Open Respir. Res. 2022;9:e001235. doi: 10.1136/bmjresp-2022-001235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2022-001235</ArticleId><ArticleId IdType="pmc">PMC9119175</ArticleId><ArticleId IdType="pubmed">35584850</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheson A.M., McIntosh M.J., Kooner H.K., Abdelrazek M., Albert M.S., Dhaliwal I., Nicholson J.M., Ouriadov A., Svenningsen S., Parraga G. Longitudinal follow-up of postacute COVID-19 syndrome: DL(CO), quality-of-life and MRI pulmonary gas-exchange abnormalities. Thorax. 2023;78:418&#x2013;421. doi: 10.1136/thorax-2022-219378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thorax-2022-219378</ArticleId><ArticleId IdType="pmc">PMC10086459</ArticleId><ArticleId IdType="pubmed">36596692</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Naidoo C.A., Usher T.J., Kruger A., Venter C., Laubscher G.J., Khan M.A., Kell D.B., Pretorius E. Seminars in Thrombosis and Hemostasis. Thieme Medical Publishers, Inc.; New York, NY, USA: 2023. Increased Levels of Inflammatory and Endothelial Biomarkers in Blood of Long COVID Patients Point to Thrombotic Endothelialitis.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-1769014</ArticleId><ArticleId IdType="pubmed">37207671</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruhe J., Giszas B., Schlosser M., Reuken P.A., Wolf G., Stallmach A. Immune adsorption for the treatment of fatigue-dominant long-/post-COVID syndrome. Dtsch. &#xc4;rzteblatt Int. 2023;120:499&#x2013;500. doi: 10.3238/arztebl.m2023.0073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2023.0073</ArticleId><ArticleId IdType="pmc">PMC10511006</ArticleId><ArticleId IdType="pubmed">37981817</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukumaran A., Thomas R.E., Krishnan R.A., Thomas T., Thomas R., Vijayan D.K., Paul J.K., Vasudevan D.M. Sequential Profiling of Anti-SARS-CoV-2 IgG Antibody in Post COVID-19 Patients. Indian. J. Clin. Biochem. 2022;37:349&#x2013;355. doi: 10.1007/s12291-021-00998-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12291-021-00998-7</ArticleId><ArticleId IdType="pmc">PMC8371431</ArticleId><ArticleId IdType="pubmed">34421232</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang H.W., Chua G.T., To K.K.W., Wong J.S.C., Tu W., Kwok J.S.Y., Wong W.H.S., Wang X., Zhang Y., Rosa Duque J.S., et al. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents. Front. Immunol. 2021;12:797919. doi: 10.3389/fimmu.2021.797919.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.797919</ArticleId><ArticleId IdType="pmc">PMC8718543</ArticleId><ArticleId IdType="pubmed">34975908</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Chiara C., Cantarutti A., Costenaro P., Dona D., Bonfante F., Cosma C., Ferrarese M., Cozzani S., Petrara M.R., Carmona F., et al. Long-term Immune Response to SARS-CoV-2 Infection Among Children and Adults after Mild Infection. JAMA Netw. Open. 2022;5:e2221616. doi: 10.1001/jamanetworkopen.2022.21616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.21616</ArticleId><ArticleId IdType="pmc">PMC9280400</ArticleId><ArticleId IdType="pubmed">35816313</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi H., Liu B., Wang X., Zhang L. The humoral response and antibodies against SARS-CoV-2 infection. Nat. Immunol. 2022;23:1008&#x2013;1020. doi: 10.1038/s41590-022-01248-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01248-5</ArticleId><ArticleId IdType="pubmed">35761083</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobano C., Ramirez-Morros A., Alonso S., Rubio R., Ruiz-Olalla G., Vidal-Alaball J., Macia D., Catalina Q.M., Vidal M., Casanovas A.F., et al. Sustained seropositivity up to 20.5 months after COVID-19. BMC Med. 2022;20:379. doi: 10.1186/s12916-022-02570-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02570-3</ArticleId><ArticleId IdType="pmc">PMC9556137</ArticleId><ArticleId IdType="pubmed">36224590</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuentes-Villalobos F., Garrido J.L., Medina M.A., Zambrano N., Ross N., Bravo F., Gaete-Argel A., Oyarzun-Arrau A., Amanat F., Soto-Rifo R., et al. Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients during Convalescence. Front. Immunol. 2022;13:796481. doi: 10.3389/fimmu.2022.796481.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.796481</ArticleId><ArticleId IdType="pmc">PMC8859986</ArticleId><ArticleId IdType="pubmed">35197972</ArticleId></ArticleIdList></Reference><Reference><Citation>Thamm R., Poethko-Muller C., Huther A., Thamm M. Allergic diseases in children and adolescents in Germany. Results of the cross-sectional KiGGS Wave 2 study and trends. J. Health Monit. 2018;3:3&#x2013;16. doi: 10.17886/RKI-GBE-2018-082.</Citation><ArticleIdList><ArticleId IdType="doi">10.17886/RKI-GBE-2018-082</ArticleId><ArticleId IdType="pmc">PMC8848849</ArticleId><ArticleId IdType="pubmed">35586803</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov I.M., Spiridonova E., Bobkova P., Gamirova A., Shikhaleva A., Andreeva M., Blyuss O., El-Taravi Y., DunnGalvin A., Comberiati P., et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur. Respir. J. 2022;59:2. doi: 10.1183/13993003.01341-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergantini L., Baldassarri M., d&#x2019;Alessandro M., Brunelli G., Fabbri G., Zguro K., Degl&#x2019;Innocenti A., Fallerini C., Bargagli E., Renieri A. Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder. Respir. Res. 2023;24:158. doi: 10.1186/s12931-023-02458-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-023-02458-7</ArticleId><ArticleId IdType="pmc">PMC10276396</ArticleId><ArticleId IdType="pubmed">37328761</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E., Levi R., Sarti R., Pozzi C., Mollura M., Mantovani A., Rescigno M. Association Between BNT162b2 Vaccination and Long COVID after Infections Not Requiring Hospitalization in Health Care Workers. JAMA. 2022;328:676&#x2013;678. doi: 10.1001/jama.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., Gupta R. Long COVID following mild SARS-CoV-2 infection: Characteristic T cell alterations and response to antihistamines. J. Investig. Med. 2022;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Kober C., Manni S., Wolff S., Barnes T., Mukherjee S., Vogel T., Hoenig L., Vogel P., Hahn A., Gerlach M., et al. IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools. PLoS ONE. 2022;17:e0262162. doi: 10.1371/journal.pone.0262162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0262162</ArticleId><ArticleId IdType="pmc">PMC8726489</ArticleId><ArticleId IdType="pubmed">34982806</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchini R., Karagiannis S.N., Jordakieva G., Jensen-Jarolim E. The Role of IgG4 in the Fine Tuning of Tolerance in IgE-Mediated Allergy and Cancer. Int. J. Mol. Sci. 2020;21:5017. doi: 10.3390/ijms21145017.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21145017</ArticleId><ArticleId IdType="pmc">PMC7404042</ArticleId><ArticleId IdType="pubmed">32708690</ArticleId></ArticleIdList></Reference><Reference><Citation>Meltendorf S., Vogel K., Thurm C., Pratsch F., Reinhold A., Farber J., Heuft H.G., Kaasch A.J., Hachenberg T., Weinzierl S., et al. IL-13 determines specific IgE responses and SARS-CoV-2 immunity after mild COVID-19 and novel mRNA vaccination. Eur. J. Immunol. 2022;52:1972&#x2013;1979. doi: 10.1002/eji.202249951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202249951</ArticleId><ArticleId IdType="pmc">PMC9874813</ArticleId><ArticleId IdType="pubmed">36271745</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Pouw Kraan T.C., Van der Zee J.S., Boeije L.C., De Groot E.R., Stapel S.O., Aarden L.A. The role of IL-13 in IgE synthesis by allergic asthma patients. Clin. Exp. Immunol. 1998;111:129&#x2013;135. doi: 10.1046/j.1365-2249.1998.00471.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.1998.00471.x</ArticleId><ArticleId IdType="pmc">PMC1904850</ArticleId><ArticleId IdType="pubmed">9472672</ArticleId></ArticleIdList></Reference><Reference><Citation>Irrgang P., Gerling J., Kocher K., Lapuente D., Steininger P., Habenicht K., Wytopil M., Beileke S., Schafer S., Zhong J., et al. Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Sci. Immunol. 2023;8:eade2798. doi: 10.1126/sciimmunol.ade2798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.ade2798</ArticleId><ArticleId IdType="pmc">PMC9847566</ArticleId><ArticleId IdType="pubmed">36548397</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadkhoda K. Post-COVID mRNA-vaccine IgG4 shift: Worrisome? mSphere. 2023;8:e00085-23. doi: 10.1128/msphere.00085-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/msphere.00085-23</ArticleId><ArticleId IdType="pmc">PMC10449502</ArticleId><ArticleId IdType="pubmed">37191589</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel J., Walter A.J., Gl&#xfc;ck V., Magnus C.L., Gl&#xfc;ck T., Schuster P., Blaas S., Montanari I., Koller M., Mohr A., et al. IgG4 serum levels are not elevated in cases of Post-COVID syndrome. bioRxiv. :2023. doi: 10.1101/2023.03.01.530454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.03.01.530454</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>